27
Participants
Start Date
October 6, 2022
Primary Completion Date
May 24, 2024
Study Completion Date
May 24, 2024
Intensive lifestyle change therapy
Participant of both groups will be followed for 24 months after completing the parent trial intervention, with no intervention during the follow-up
Tirzepatide
Participant of both groups will be followed for 24 months after completing the parent trial intervention, with no intervention during the follow-up
Pennington Biomedical Research Center, Baton Rouge
Pennington Biomedical Research Center
OTHER